Long-term effects of immunosuppressive therapy on lung function in scleroderma patients.

导出原文传递

翻译打印收藏纠错

第一作者： Slavica,Pavlov-Dolijanovic

第一单位： Faculty of Medicine, University of Belgrade, Institute of Rheumatology Belgrade, Serbia, Resavska 69, Belgrade, 11000, Serbia. dolijan@eunet.rs.

作者： Slavica,Pavlov-Dolijanovic ^[1] ; Nada,Vujasinovic Stupar ^[2] ; Vladimir,Zugic ^[3] ; Predrag,Ostojic ^[2] ; Ana,Zekovic ^[4] ; Tatjana,Zivanovic Radnic ^[4] ; Ivan,Jeremic ^[4] ; Ivana,Tadic ^[5]

作者单位： Faculty of Medicine, University of Belgrade, Institute of Rheumatology Belgrade, Serbia, Resavska 69, Belgrade, 11000, Serbia. dolijan@eunet.rs. ^[1] Faculty of Medicine, University of Belgrade, Institute of Rheumatology Belgrade, Serbia, Resavska 69, Belgrade, 11000, Serbia. ^[2] Faculty of Medicine University of Belgrade, Clinic for Pulmology, Clinical Center of Serbia, Belgrade, Serbia. ^[3] Institute of Rheumatology, Resavska 69, Belgrade, 11000, Serbia. ^[4] Faculty of Pharmacy Department of Social Pharmacy and Pharmacy Legislation, University of Belgrade Faculty of Pharmacy, Vojvode Stepe 450, Belgrade, 11000, Serbia. ^[5]

关键词 Cyclophosphamide pulse therapy Follow-up Immunosuppressants Interstitisal lung disease Lung function Systemic sclerosis